You have 9 free searches left this month | for more free features.

tak-228

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)

Terminated
  • Soft-tissue Sarcoma
  • TAK-228
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 19, 2022

Advanced Solid Tumor Trial in Sioux Falls (paclitaxel, TAK-228, TAK-117)

Active, not recruiting
  • Advanced Solid Tumor
  • Sioux Falls, South Dakota
    Avera Cancer Institute
Aug 24, 2021

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Advanced Nonhematological Tumors Trial in Japan, Korea, Republic of, Taiwan (TAK-228)

Terminated
  • Advanced Nonhematological Neoplasms
  • TAK-228
  • Kashiwa-shi, Chiba-Ken, Japan
  • +3 more
Apr 22, 2021

Breast Cancer Trial in Lebanon (TAK-228, Letrozole)

Withdrawn
  • Breast Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Mar 10, 2020

Advanced Nonhematologic Malignancies Trial in Spain, United Kingdom, United States (TAK-228, TAK-117)

Completed
  • Advanced Nonhematologic Malignancies
  • Boston, Massachusetts
  • +4 more
Oct 7, 2019

Malignant Tumors of Digestive Organs, Malignant Tumors of Female Genital Organs, Malignant Tumors of Lip Oral Cavity and Pharynx

Withdrawn
  • Malignant Neoplasms of Digestive Organs
  • +3 more
  • (no location specified)
Mar 24, 2017